CHAI is supporting the Senegalese government to introduce new HIV and human papillomavirus (HPV) treatment and diagnostic programs, as well as to achieve sustainable health financing.
We began working with the Senegalese government in 2018 to accelerate access to early infant diagnostic and viral load testing for HIV, reduce test turnaround times and speed up patient linkage into care. We are also working to increase access to the latest and best HIV treatments including Tenofovir, Lamivudine, and Dolutegravir (TLD), the WHO recommended first-line treatment for people living with HIV.
We are helping the Senegalese government implement an HPV pilot project to demonstrate the feasibility of integrating HPV testing and precancerous lesions treatment into routine healthcare for cervical cancer prevention.
We are also supporting the Universal Health Coverage Agency (UHCA) and the Ministry of Health to map resources and track expenditures across the entire healthcare system, as well as identify gaps in the national free-care program for children under five.
of HIV positive infants diagnosed on point-of-care initiated on treatment within one week of results
adults living with HIV receiving treatment in 2019, of which 50 percent will receive optimal medication TLD by 2020
children living with HIV receiving treatment in 2019, up from 1,614 in 2018